
In a previous accounting report, Pharmacosmos warned that it would probably end the year with a deficit on the bottom line, its first in 15 years -- and this prediction came true.
The company has ended its 2020/2021 financial year with a total deficit of USD 19.7m, a contrast to the USD 8m profit the company reported in its last accounting year.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app